27325547|t|Benchmark study on fine-mode aerosol in a big urban area and relevant doses deposited in the human respiratory tract
27325547|a|It is well-known that the health effects of PM increase as particle size decreases: particularly, great concern has risen on the role of UltraFine Particles (UFPs). Starting from the knowledge that the main fraction of atmospheric aerosol in Rome is characterized by significant levels of PM2.5 (almost 75% of PM10 fraction is PM2.5), the paper is focused on submicron particles in such great urban area. The daytime / nighttime, work- / weekdays and cold / hot seasonal trends of submicron particles will be investigated and discussed along with NOx and total PAH drifts demonstrating the primary origin of UFPs from combustion processes. Furthermore, moving from these data, the total dose of submicron particles deposited in the respiratory system (i.e., head, tracheobronchial and alveolar regions in different lung lobes) has been estimated. Dosimeter estimates were performed with the Multiple-Path Particle Dosimetry model (MPPD v.2.1). The paper discusses the aerosol doses deposited in the respiratory system of individuals exposed in proximity of traffic. During traffic peak hours, about 6.6 Ã— 10(10) particles are deposited into the respiratory system. Such dose is almost entirely made of UFPs. According to the greater dose estimated, right lung lobes are expected to be more susceptible to respiratory pathologies than left lobes.
27325547	10	15	study	T062	C2603343
27325547	19	36	fine-mode aerosol	T073	C0001712
27325547	42	56	big urban area	UnknownType	C0814837
27325547	61	75	relevant doses	T081	C0178602
27325547	76	85	deposited	T169	C0333562
27325547	93	98	human	T016	C0086418
27325547	99	116	respiratory tract	T023	C0282335
27325547	143	149	health	T078	C0018684
27325547	150	157	effects	T080	C1280500
27325547	161	163	PM	T131	C1510837
27325547	176	189	particle size	T081	C0030608
27325547	254	273	UltraFine Particles	T104	C0597177
27325547	275	279	UFPs	T104	C0597177
27325547	324	335	fraction of	T081	C1264633
27325547	336	347	atmospheric	T070	C0004178
27325547	348	355	aerosol	T073	C0001712
27325547	359	363	Rome	T083	C0035831
27325547	396	402	levels	T080	C0441889
27325547	406	411	PM2.5	T131	C1510837
27325547	427	431	PM10	T131	C1510837
27325547	444	449	PM2.5	T131	C1510837
27325547	476	495	submicron particles	T104	C0597177
27325547	504	520	great urban area	UnknownType	C0814837
27325547	526	533	daytime	T079	C0332169
27325547	536	545	nighttime	T079	C3844540
27325547	547	552	work-	T079	C0680192
27325547	555	563	weekdays	T079	C0680189
27325547	568	572	cold	T070	C0009264
27325547	575	578	hot	T070	C2350229
27325547	579	594	seasonal trends	T079	C0036497
27325547	598	617	submicron particles	T104	C0597177
27325547	664	667	NOx	T197	C0028167
27325547	678	681	PAH	T109	C0032458
27325547	725	729	UFPs	T104	C0597177
27325547	735	755	combustion processes	T067	C1522240
27325547	804	808	dose	T081	C0178602
27325547	812	831	submicron particles	T104	C0597177
27325547	832	841	deposited	T169	C0333562
27325547	849	867	respiratory system	T022	C0035237
27325547	875	879	head	T029	C0018670
27325547	881	897	tracheobronchial	T023	C0458580
27325547	902	918	alveolar regions	T023	C1440080
27325547	932	942	lung lobes	T023	C0225752
27325547	964	973	Dosimeter	T074	C0180488
27325547	974	983	estimates	T081	C0750572
27325547	1008	1046	Multiple-Path Particle Dosimetry model	T170	C3161035
27325547	1048	1058	MPPD v.2.1	T170	C3161035
27325547	1085	1092	aerosol	T073	C0001712
27325547	1093	1098	doses	T081	C0178602
27325547	1099	1108	deposited	T169	C0333562
27325547	1116	1134	respiratory system	T022	C0035237
27325547	1138	1149	individuals	T098	C0237401
27325547	1150	1157	exposed	T080	C0332157
27325547	1174	1181	traffic	T033	C3840880
27325547	1190	1197	traffic	T033	C3840880
27325547	1203	1208	hours	T079	C0439227
27325547	1229	1238	particles	T104	C0597177
27325547	1243	1252	deposited	T169	C0333562
27325547	1262	1280	respiratory system	T022	C0035237
27325547	1287	1291	dose	T081	C0178602
27325547	1319	1323	UFPs	T104	C0597177
27325547	1350	1354	dose	T081	C0178602
27325547	1355	1364	estimated	T081	C0750572
27325547	1366	1382	right lung lobes	T023	C0446959
27325547	1407	1418	susceptible	T169	C0231204
27325547	1422	1433	respiratory	T169	C0521346
27325547	1434	1445	pathologies	T046	C0677042
27325547	1451	1461	left lobes	T023	C0446960